All lobbying filings

TIBER CREEK GROUP

Lobbying for ASTRAZENECA

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $90,000.00 income · posted Jul 19, 2025

Official filing document

Bills named in this filing 2

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act

Lobbying activity 1

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.